8th April 2021
Polar Capital Global Healthcare Trust plc (the "Company")
Top Ten Equity Holdings and Sector and Geographic Exposure as at 31st March 2021 and full portfolio listing as at 26th February 2021 is available from the company's website
Polar Capital Global Healthcare Trust plc is pleased to announce that as at 31st March 2021 the top ten equity holdings and the sector and geographic breakdown were as follows:
| Top 10 Holdings | % |
| UnitedHealth Group | 6.4% |
| Medtronic | 5.0% |
| AstraZeneca | 4.5% |
| Bio-Rad Laboratories | 4.3% |
| Sanofi | 4.1% |
| Bristol Myers Squibb | 3.9% |
| Koninklijke Philips | 3.6% |
| Baxter International | 3.6% |
| Align Technology | 3.2% |
| Amgen | 3.0% |
| Total | 41.5% |
| Sector Exposure | % |
| Healthcare Equipment | 21.3% |
| Biotechnology | 20.5% |
| Pharmaceuticals | 16.5% |
| Managed Healthcare | 11.5% |
| Life Sciences Tools & Services | 11.4% |
| Healthcare Distributors | 5.7% |
| Healthcare Supplies | 5.6% |
| Healthcare Facilities | 5.1% |
| Healthcare Technology | 2.9% |
| Metal & Glass Containers | 2.1% |
| Cash | -2.7% |
| Total | 100.0% |
| Geographic Exposure | % |
| United States | 67.2% |
| Ireland | 6.3% |
| United Kingdom | 5.7% |
| Netherlands | 5.6% |
| France | 4.1% |
| Denmark | 3.6% |
| Australia | 2.6% |
| Japan | 2.6% |
| Germany | 2.6% |
| Sweden | 1.4% |
| Switzerland | 1.0% |
| Cash | -2.7% |
| Total | 100.0% |
Gearing Ratio as calculated in accordance with the guidelines of the Association of Investment Companies, was 2.8%. Gearing is made up of structural debt provided by the subsidiary company PCGH ZDP plc, through the issue of zero dividend preference (ZDP) shares.
The ZDP asset cover as at 31st March 2021 was 9.40x.
The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager. www.Polarcapitalhealthcaretrust.com
Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
